Improve Research Reproducibility A Bio-protocol resource
bpdetail_icon_lock
Preprint

Complex preparation and crystallization

ST Shuguang Tan
HF Hui Feng
JY Jinghua Yan

Last updated date: Jul 5, 2021 Views: 795 Forks: 0

original An abbreviated version of this protocol was published in mAbs
Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy
download pdf Download PDF
ask Ask a question
cite How to cite
nfavorite Favorite

The mammalian cell expressed PD-1 protein and toripalimab-Fab fragment were mixed at a molar ration of 1:1. The mixture was incubated on ice for 30 min and further purified by SuperdexTM 200 10/300 GL (GE Healthcare). 10 mg/mL of toripalimab/PD-1 proteins were used for crystal screening by vapour-diffusion sitting-drop method at 4°C. Diffractable crystals were obtained in a condition consisting of 0.09 M Halogens consisting of NaF, NaBr and NaI additives, 0.1 M Tris-Base (pH8.5), 37.5% (v/v) MPD-P1K-P3350 consisting of MPD (racemic), PEG 1K and PEG 3350 (Morpheus® MD1–46 kit, Molecular Dimensions).

Copyright: Content may be subjected to copyright.
How to cite：
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
  1. Tan, S, Feng, H and Yan, J(2021). Complex preparation and crystallization. Bio-protocol Preprint. bio-protocol.org/prep1258.
  2. Liu, H., Guo, L., Zhang, J., Zhou, Y., Zhou, J., Yao, J., Wu, H., Yao, S., Chen, B., Chai, Y., Qi, J., Gao, G. F., Tan, S., Feng, H. and Yan, J.(2019). Glycosylation-independent binding of monoclonal antibody toripalimab to FG loop of PD-1 for tumor immune checkpoint therapy. mAbs 11(4). DOI: 10.1080/19420862.2019.1596513

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A
This protocol preprint was submitted via the "Request a Protocol" track.